Buti M, Domínguez-Hernández R, Casado MA, Sabater E, Esteban R
Cost- effectiveness of screening for hepatitis C virus in population born between 1956 and 1970, in Spain
The International Liver Congress™ 2017. 52st Annual Meeting of the European Asocciation for the Study of the Liver (EASL). Amsterdam, Netherlands. 19-23 apr 2017
Buti M, Crespo J, Esteban R, Torres C, Oyagüez I, Casado MA
Cost-effectiveness analysis of hepatitis B virus screening to prevent hepatitis B virus reactivation in patients receiving rituximab based chemotherapy for hematologic malignancy
51st International Liver Congress. European Association for the Study of the liver (EASL). Barcelona, Spain. 13- 17 apr 2016
Buti M, Dominguez R, Oyagüez I, Rueda M, Casado MA
Early versus delayed use of Sofosbuvir plus Peginterferon/Ribavirin therapy in fibrosis patients with hepatitis C virus: A cost-effectiveness analysis
50th International Liver Congress (EASL). Vienna, Austria. 22- 26 apr 2015
Deniz B, Buti M, Brosa M, Casado MA, Rueda M, Everhard F, Esteban R
Cost-effectiveness simulation analysis of tenofovir disoproxil fumarate, lamivudine, adefovir dipivoxil and entecavir of HBeaAg negative patients with chronic hepatitis-B in Spain
43rd Annual Meeting of the European Association for the Study of the Liver (EASL). Milan, Italy. 23-27 apr 2008
Buti M, Casado MA, Calleja JL, Salmerón J, Aguilar J, Rueda M, Esteban R
The improved therapeutic effects of adefovir dipivoxil in patients with HBe-Ag-negative chronic hepatitis B offset against its increased cost compared to lamivudine
41st Annual Meeting of the European Association for the Study of the Liver (EASL). Vienna, Austria. 26-30 apr 2006
Wong JB, Buti M, Casado MA, Fosbrook L, Soriano V, Esteban R
Cost-effectiveness of peginterferon alfa-2b plus ribavirin for chronic hepatitis C in HIV-HCV co-infected patients
40th Annual Meeting of the European Association for the Study of the Liver (EASL). Paris, France. 13-17 apr 2005
Buti M, Casado MA, Calleja JL, Salmerón J, Aguilar J, Rueda M, Esteban R
Cost-effectiveness of two oral antiviral therapies, lamivudine and adefovir dipivoxil of HBeAg-negative chronic hepatitis B
40th Annual Meeting of the European Association for the Study of the Liver (EASL). Paris, France. 13-17 apr 2005
Buti M, Wong J, Casado MA, Esteban R